Clot Care Images
DVT Awareness | Join Our Email List | Wednesday, April 26, 2017

Prasugrel (New Antiplatelet Agent) Approved in Europe

Marie B. Walker
February, 2009

While controversy has surrounded the FDA Panel's review of Prasugrel in the US, the drug has been approved by the European Commission. Prasugrel will be marketed as Efient in Europe.

Click here to read more about this decision on theheart.org.

Copyright 2000-2012 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
Send comments to webmaster@clotcare.org.
ClotCare is a charitable 501(c)(3) non-profit organization. Click here to donate.
ClotCare Online Resource covers topics such as Coumadin, warfarin, blood clot, stroke, heart attack, INR, PT, low molecular weight haparin, heparin, dvt, anticoagulation, antithrombotic therapy, A. fib, atrial fibrillation, heart valve, heart valve replacement, vitamin k, AstraZeneca, Aventis, CE credit, and more.